We therefore combined methylation data from patient tumor tissues and cell lines following decitabine treatment to converge on six genes (CRIP1, G0S2, MLH1, OPN3, S100 and TUBB2A) as the classifier. The gene discussed is G0S2; the disease is neoplasm.